2020 Scientific Sessions

TAVR in the COVID-19 Era and Beyond

This activity is supported by an unrestricted educational grant from Edwards Lifesciences. No in-kind commercial support was received.
Optimizing Your TAVR Program During the COVID-19 Pandemic
Bassem M. Chehab, M.D., FSCAI, Ascension Via Christi Health, Wichita, KS
Best Practice: TAVR 2020
Pinak Bipin Shah, M.D., FSCAI, Brigham and Women's Hospital, Boston, MA
Heart Team Decisions: Making the Hard Calls in the Low-Risk Patient
Steven R. Bailey, M.D., MSCAI, Louisiana State University Health Sciences Center, San Antonio, TX
See more of: Satellite Sessions
<< Previous Satellite | Next Satellite >>